Creating Pharmacist Prescribing Authority Act

Added a 30-day supply limit within a six-month period for all prescriptions dispensed or prescribed under the new pharmacist authority.

Requires pharmacists to notify the patient's primary care physician if more than 10 days of medication is prescribed or dispensed.

Bill title was updated to clarify the purpose of the legislation regarding pharmacist prescribing authority and testing limitations.

Pharmacists must notify patients' primary care physicians within 72 hours when prescribing drugs based on test results or dispensing medications.

Prescriptions under this authority are limited to a 30-day supply within a 6-month period, with referral requirements if no primary care physician is identified.

Pharmacists may now prescribe non-controlled drugs that match FDA-approved labeling when guided by specific waived tests for influenza, SARS-COV-2, and RSV.

Pharmacists are authorized to administer immunizations when meeting requirements established through legislative rule.

Pharmacist prescribing authority was restricted from general minor conditions to only influenza, SARS-COV-2, RSV, and expired epinephrine injection refills.

New requirement mandates pharmacists notify the patient's primary care physician within 72 hours of prescribing.

New supply limits restrict prescriptions to a 30-day supply within a 6-month period, with additional notification requirements if more than 10 days are prescribed.

Removed the exemption from review requirements for the new pharmacist prescribing authority.

Article structure changed from Article 5A (new pharmacist prescribing authority) to Article 5 (general pharmacist scope of practice), integrating prescribing authority into broader pharmacy practice provisions.

Added a requirement that pharmacists must take a patient medication history before prescribing low-risk medications.

Clarified that diagnostic tests used to support prescribing must indicate conditions that are minor and generally self-limiting.

Added a new requirement for pharmacists to notify the patient's primary care physician within 72 hours of prescribing, if the physician is identified.

Added new Article 5A creating the Pharmacist Prescribing Authority Act with expanded prescribing conditions including patient emergencies and self-limiting conditions.

Modified prescribing conditions to include four categories: conditions not requiring new diagnosis, minor self-limiting conditions, CLIA-waived tests, and pharmacist-judgment patient emergencies.

Added exemption from sunrise review requirements to allow immediate implementation of the new prescribing authority.

Removed original formatting and certification language from the enrolled version, replacing with new article structure and purpose statement.

Changed from creating a new Article 5A to amending existing Article 5, Section 30-5-10, integrating pharmacist prescribing authority into the current pharmacy practice framework.

Added specific conditions for pharmacist prescribing: tests must be waived under CLIA and indicate only influenza, SARS-COV-2, RSV, or refill expired epinephrine injection prescriptions.

Added requirement for pharmacists to notify patients' primary care physicians within 72 hours of test results and permissible drug prescriptions.

Modified prescription limits from general 'low-risk medications' to specific conditions and added requirement to notify primary care physician if more than 10 days is prescribed or dispensed.

Added requirement for pharmacists to attempt patient referral to primary care physician if none is identified.

Added a new section 30-5A-4 exempting the pharmacist prescribing authority from sunrise review requirements under 30-1A-1 et seq.

Clarified the scope of pharmacy practice to include specific conditions: no new diagnosis required, tests waived under CLIA indicating minor/self-limiting conditions, patient emergencies, and notification requirements for primary care physicians.

Added a 30-day supply limit within a six-month period, with notification required to primary care physician if more than 10 days is prescribed or dispensed.